Roches headquarters in Basel sunset in the background
Pharma

Vabysmo shows signs of recovery as Roche gears up for busy 2027

As the Vabysmo market stabilizes, Roche and investors are turning their attention to several potential blockbuster launches in the next few months.
Angus Liu Oct 22, 2026 11:20am
Podcast
The Next Chapter for AI in Clinical Trials

The Next Chapter for AI in Clinical Trials

Brought to you by Saama
ESMO AstraZeneca

AZ lands 5th Ultomiris indication in kidney disease IgAN

Oct 22, 2026 11:15am
Why Are 53 of Phase 2 and 3 Trials Delayed A Redesign Is Overdue

Why Are 53% of Phase 2 and 3 Trials Delayed? A Redesign Is Overdue

Brought to you by Bain & Company
China

Esteve pledges $80M to overhaul its CDMO operations in China

Oct 22, 2026 10:52am
Businesspeople walking towards a bright light at the end of a white corridor

Pfizer's cost savings drive touches jobs at US, Europe plants

Oct 22, 2026 9:32am
More News

Roivant eyes Humira's throne in NIU after Lisraya ph. 3 win

Oct 22, 2026 8:04am

AbbVie pumps up the case for early subcutaneous Parkinson’s care

Oct 22, 2026 6:32am

Otsuka hit with marketing breaches after event organizer blunder

Oct 22, 2026 2:23am

Direct-to-patient pharma programs transform drug access: survey

Oct 21, 2026 1:24pm